This suggests that the mechanism of action of KRT17 in malignant tumors is complex and diverse, that there may be multiple mechanisms in one tumor, and that multiple tumors may share similar mechanisms (Li et al., 2019; Liu et al., 2020; Zeng et al., 2020). The gene discussed is KRT17; the disease is cancer.